Synthesis of Novel Arginine Building Blocks with Increased Lipophilicity Compatible with Solid-Phase Peptide Synthesis.
SPPS
arginine building blocks
increased lipophilicity
prodrugs
vasopressin
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
25 Nov 2023
25 Nov 2023
Historique:
received:
25
10
2023
revised:
15
11
2023
accepted:
23
11
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
9
12
2023
Statut:
epublish
Résumé
Arginine, due to the guanidine moiety, increases peptides' hydrophilicity and enables interactions with charged molecules, but at the same time, its presence in a peptide chain might reduce its permeability through biological membranes. This might be resolved by temporary coverage of the peptide charge by lipophilic, enzyme-sensitive alkoxycarbonyl groups. Unfortunately, such a modification of a guanidine moiety has not been reported to date and turned out to be challenging. Here, we present a new, optimized strategy to obtain arginine building blocks with increased lipophilicity that were successfully utilized in the solid-phase peptide synthesis of novel arginine vasopressin prodrugs.
Identifiants
pubmed: 38067510
pii: molecules28237780
doi: 10.3390/molecules28237780
pmc: PMC10708530
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Science Center
ID : 2019/35/D/NZ7/00174
Références
Chem Rev. 2005 Jan;105(1):67-114
pubmed: 15720152
J Org Chem. 2010 Aug 6;75(15):5371-4
pubmed: 20583745
Methods Mol Biol. 2013;1081:151-65
pubmed: 24014439
Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438
pubmed: 30144240
Drug Metab Dispos. 2008 Feb;36(2):386-99
pubmed: 18006647
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9459-64
pubmed: 10449714
FEBS Lett. 1986 Jul 28;203(2):139-43
pubmed: 3089835
Anal Biochem. 1970 Apr;34(2):595-8
pubmed: 5443684
Expert Opin Pharmacother. 2010 Jun;11(8):1403-11
pubmed: 20446854
Org Lett. 2020 Oct 16;22(20):8039-8043
pubmed: 33006475
Nat Prod Rep. 1996 Oct;13(5):377-409
pubmed: 8888608
Acta Pharm Sin B. 2018 Sep;8(5):699-712
pubmed: 30245959
Chem Soc Rev. 2020 Jun 7;49(11):3262-3277
pubmed: 32255135
J Med Chem. 2015 Apr 9;58(7):2895-940
pubmed: 25565044
Protein Sci. 1994 Aug;3(8):1267-75
pubmed: 7987222
Pept Res. 1995 Jul-Aug;8(4):236-7
pubmed: 8527877
Angew Chem Int Ed Engl. 2017 Dec 18;56(51):16405-16409
pubmed: 29072809
J Comb Chem. 2008 Sep-Oct;10(5):681-90
pubmed: 18683986
Bioconjug Chem. 2019 May 15;30(5):1309-1313
pubmed: 30978287
J Org Chem. 2020 Feb 7;85(3):1484-1494
pubmed: 31789513
Org Lett. 2016 Jun 3;18(11):2788-91
pubmed: 27191730
J Pept Sci. 2023 Sep;29(9):e3489
pubmed: 36967632
Mol Pharm. 2018 Aug 6;15(8):3468-3477
pubmed: 29976060
Drug Discov Today. 2023 Feb;28(2):103464
pubmed: 36481586
Int J Mol Sci. 2022 Mar 12;23(6):
pubmed: 35328489
Beilstein J Org Chem. 2014 Mar 04;10:544-98
pubmed: 24605172